Couples Coping With Multiple Chronic Medical Conditions
NCT ID: NCT01912157
Last Updated: 2018-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2013-07-31
2018-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Intervention : Expressive Writing about subjective illness perception vs. Writing about individual Time-Management Primary Endpoint: subjective Health (e.g. SF 12 questionnaire) Secondary Endpoints: Psychosocial Adjustments (Depression, somatic symptoms, quality of partnership and others)
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary endpoint: subjective health (SF 12 questionnaire) Secondary endpoint: psychosocial adjustments (depression, positive and negative affect, somatic symptoms, adjustment disorder, marital satisfaction, sleep quality)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Intervention
The control condition are 3 sessions writing about individual time-management (placebo).
Expressive Writing
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing)
Expressive Writing
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing).
Expressive Writing
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expressive Writing
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* multimorbid condition (two or more chronic medical conditions)
* patients living with romantic partner
* very good oral and written command in German
* written consent for participation by patient and partner
Exclusion Criteria
* Mini Mental State less than 26
* Substance Abuse
* Patients in Palliative Situation
* Patients isolated due to infectious diseases
* Patients participating in other clinical trials within the last 4 weeks before inclusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukas Zimmerli, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Internal Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Internal Medicine
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH 2013-0009_GUGKS
Identifier Type: -
Identifier Source: org_study_id